These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 37261603)

  • 1. Extracellular vesicle-based drug delivery in cancer immunotherapy.
    Najafi S; Majidpoor J; Mortezaee K
    Drug Deliv Transl Res; 2023 Nov; 13(11):2790-2806. PubMed ID: 37261603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicle-mediated immunoregulation in cancer.
    Yamamoto T; Yamamoto Y; Ochiya T
    Int J Hematol; 2023 May; 117(5):640-646. PubMed ID: 35951282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer.
    de Miguel-Perez D; Russo A; Gunasekaran M; Buemi F; Hester L; Fan X; Carter-Cooper BA; Lapidus RG; Peleg A; Arroyo-Hernández M; Cardona AF; Naing A; Hirsch FR; Mack PC; Kaushal S; Serrano MJ; Adamo V; Arrieta O; Rolfo C
    Cancer; 2023 Feb; 129(4):521-530. PubMed ID: 36484171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicle-based checkpoint regulation and immune state in cancer.
    Mortezaee K; Majidpoor J
    Med Oncol; 2022 Sep; 39(12):225. PubMed ID: 36175741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of engineered extracellular vesicles with full-length functional PD-1 membrane proteins by baculovirus expression system.
    Ishikawa R; Yoshida S; Sawada SI; Sasaki Y; Akiyoshi K
    Biochem Biophys Res Commun; 2020 Jun; 526(4):967-972. PubMed ID: 32299612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.
    Xia L; Liu Y; Wang Y
    Oncologist; 2019 Feb; 24(Suppl 1):S31-S41. PubMed ID: 30819829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances and challenges of immune checkpoint inhibitors in immunotherapy of non-small cell lung cancer.
    Wu Z; Man S; Sun R; Li Z; Wu Y; Zuo D
    Int Immunopharmacol; 2020 Aug; 85():106613. PubMed ID: 32450531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1.
    Lee CH; Bae JH; Choe EJ; Park JM; Park SS; Cho HJ; Song BJ; Baek MC
    Theranostics; 2022; 12(5):1971-1987. PubMed ID: 35265193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Capturing and Chemiluminescent Sensing of Programmed Death Ligand-1 Expressing Extracellular Vesicles.
    Khan A; Di K; Khan H; He N; Li Z
    Biosensors (Basel); 2022 Apr; 12(5):. PubMed ID: 35624582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research Advances of Immunotherapy of Exosome PD-L1 
in Non-small Cell Lung Cancer].
    Wang N; Song X
    Zhongguo Fei Ai Za Zhi; 2022 Sep; 25(9):689-695. PubMed ID: 36172735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles containing PD-L1 contribute to CD8+ T-cell immune suppression and predict poor outcomes in small cell lung cancer.
    Dou X; Hua Y; Chen Z; Chao F; Li M
    Clin Exp Immunol; 2022 May; 207(3):307-317. PubMed ID: 35553630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages.
    Liu Y; Lu M; Chen J; Li S; Deng Y; Yang S; Ou Q; Li J; Gao P; Luo Z; Yuan P; Tan J; Gao X
    Sleep Breath; 2022 Jun; 26(2):893-906. PubMed ID: 34254261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicles in the Development of Cancer Therapeutics.
    Sun H; Burrola S; Wu J; Ding WQ
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in Advanced Non-Small Cell Lung Cancer.
    Huang J; Reckamp KL
    Semin Respir Crit Care Med; 2020 Jun; 41(3):400-408. PubMed ID: 32450594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Cell-Derived Extracellular Vesicles - Functions and Therapeutic Applications.
    Veerman RE; Güçlüler Akpinar G; Eldh M; Gabrielsson S
    Trends Mol Med; 2019 May; 25(5):382-394. PubMed ID: 30853173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer.
    de Miguel-Perez D; Russo A; Arrieta O; Ak M; Barron F; Gunasekaran M; Mamindla P; Lara-Mejia L; Peterson CB; Er ME; Peddagangireddy V; Buemi F; Cooper B; Manca P; Lapidus RG; Hsia RC; Cardona AF; Naing A; Kaushal S; Hirsch FR; Mack PC; Serrano MJ; Adamo V; Colen RR; Rolfo C
    J Exp Clin Cancer Res; 2022 Jun; 41(1):186. PubMed ID: 35650597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with PD-1 or PD-L1 inhibitors for cancer.
    Hayashi H; Nakagawa K
    Int J Clin Oncol; 2020 May; 25(5):818-830. PubMed ID: 31549270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles at the crossroad between cancer progression and immunotherapy: focus on dendritic cells.
    Schioppa T; Gaudenzi C; Zucchi G; Piserà A; Vahidi Y; Tiberio L; Sozzani S; Del Prete A; Bosisio D; Salvi V
    J Transl Med; 2024 Jul; 22(1):691. PubMed ID: 39075551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint inhibitors in non-small-cell lung cancer: current status and future directions.
    Yan YF; Zheng YF; Ming PP; Deng XX; Ge W; Wu YG
    Brief Funct Genomics; 2019 Mar; 18(2):147-156. PubMed ID: 30247518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment of circulating tumor-derived extracellular vesicles from human plasma.
    Yoh KE; Lowe CJ; Mahajan S; Suttmann R; Nguy T; Reichelt M; Yang J; Melendez R; Li Y; Molinero L; Ruppel J; Xu W; Plaks V
    J Immunol Methods; 2021 Mar; 490():112936. PubMed ID: 33242493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.